z-logo
open-access-imgOpen Access
The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus
Author(s) -
Jing Tian,
Yan Ma,
Jing Li,
Han Cen,
Deguang Wang,
Chen-Chen Feng,
Ruo-Jie Li,
RuiXue Leng,
HaiFeng Pan,
Dong-Qing Ye
Publication year - 2012
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2012.865
Subject(s) - genotyping , genotype , taqman , immunology , single nucleotide polymorphism , medicine , lupus nephritis , biology , polymorphism (computer science) , polymerase chain reaction , genetics , gene , disease
Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder that predominantly affects women of childbearing age, with a female-to-male ratio of approximately 9:1. Previous findings indicated that male cases of SLE were associated with Klinefelter's syndrome (47, XXY), whereas females with Turner's syndrome (45, X0) did not contract SLE. Additionally, duplicated Toll-like receptor 7 (TLR7) was found to promote lupus-like disease. Consequently, the aim of this study was to evaluate whether the TLR7 gene served as a genetic marker for the development of SLE. A case-control study was performed on one tag single nucleotide polymorphism TLR7 rs1634323 in a population with 507 SLE patients and 513 healthy controls. Genotyping was determined by the TaqMan genotyping assay using the ABI 7300 real-time reverse transcription polymerase chain reaction system. The results showed a significantly elevated risk of SLE with the rs1634323 AG genotype in females (P = 0.040, OR = 1.897, 95% CI 1.031-3.491), whereas a similar association was not replicated in males (P = 0.303, OR = 0.338, 95% CI 0.043-2.656). In a subgroup analysis by clinical manifestation of lupus nephritis, no significant differences were found. These findings indicate that the TLR7 gene rs1634323 polymorphism may contribute to SLE susceptibility in females.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here